{"id":7811,"date":"2025-05-02T13:45:00","date_gmt":"2025-05-02T11:45:00","guid":{"rendered":"https:\/\/www.msd.ch\/en\/?post_type=story&p=7811"},"modified":"2025-05-04T18:47:36","modified_gmt":"2025-05-04T16:47:36","slug":"women-at-msd","status":"publish","type":"story","link":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/","title":{"rendered":"Women at MSD"},"content":{"rendered":"\n
\n
\n \n \n Diversity and inclusion<\/small>\n <\/a>\n \n \n

\n Women at MSD\n <\/h1>\n

In the company\u2019s more than 130-year history, many women have helped shape MSD. <\/p>\n <\/div>\n\n

\n

02.05.2025<\/p>\n

\n

Share this article<\/p>\n

\n \nFacebook icon<\/title><\/svg>\n<\/a><\/p>\n

\n\n\n\n\t.st0{fill:#00857C;}\n\n\nX icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nLinkedin icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nEmail icon<\/title><\/svg>\n<\/a><\/p>\n <\/div>\n <\/div>\n\n
\n
\n
\n \n \n \n \n \"Women\n <\/picture>\n\n <\/figure>\n \n <\/div>\n <\/div>\n\n
\n
\n
\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n\n

We introduce eight remarkable women who have paved the way for future generations.<\/p>\n\n\n\n\n

\n
<\/div>

01.<\/p><\/div>

<\/div><\/div>
\n

Ann Colon,<\/h3>\n\n\n\n

the first woman to celebrate 50 years with MSD.<\/h4>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Anna “Ann” Colon started in MSD’s packaging department in 1919. She became a manager in 1933.<\/p>\n\n\n\n

When she retired after more than 50 years with MSD, she was the longest-tenured female employee in the company to date.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

<\/div>

02.<\/p><\/div>

<\/div><\/div>
\n
\n
\n

Grace Winterling,<\/h3>\n\n\n\n

the first female corporate officer at MSD.<\/h4>\n\n\n\n

Grace Winterling began her career during World War II in the Priorities Department before taking on supervisory roles in the Systems and Procedures, Organizational Planning, and Office Services Divisions.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

In 1954, she became an administrative assistant to the Corporate Secretary. She was elected to Assistant Secretary in 1957 \u2013 a role that made her the first woman to become one of the companies corporate officers. The fact that a female executive had been named was so remarkable that it made headlines in local newspapers.<\/p>\n\n\n\n

After 15 years in corporate leadership, Grace was named president of the company’s Foundation, which continues continues to fund qualified, eligible nonprofit and philanthropic organizations today. Grace retired in 1983 after 40 years with MSD.<\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

03.<\/p><\/div>

<\/div><\/div>
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Susan Jenkins,<\/h3>\n\n\n\n

the first african-american female chemist at MSD.<\/h4>\n\n\n\n

Susan R. Jenkins started at MSD Research Laboratories (MRL) in 1957 as one of the first African-American female chemists in the company, working on synthesizing enzymes, in addition to other activities.<\/p>\n<\/div>\n<\/div>\n\n\n\n

She later moved to Human Resources, where she held various leadership positions, most recently as Senior Vice President of Human Resources.<\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

04.<\/p><\/div>

<\/div><\/div>
\n
\n
\n

Marian S. Heiskell,<\/h3>\n\n\n\n

MSD\u2019s first woman elected to Board of Directors.<\/h4>\n\n\n\n

Marian S. Heiskell, Director of Special Activities at the New York Times Company, became the first woman elected to MSD’s Board of Directors in 1973. <\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

She retained her seat on the Board for 18 years until she stepped down in 1991. Marian Heiskell was a well-known philanthropist and newspaper executive and died in 2019 at the age of 100.<\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

05.<\/p><\/div>

<\/div><\/div>
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Dorothy Bowers,<\/h3>\n\n\n\n

MSD\u2019s first vice president of environmental and safety policy.<\/h4>\n\n\n\n

Dorothy Bowers joined MSD in 1974 as an engineer in the Environmental Department.<\/p>\n<\/div>\n<\/div>\n\n\n\n

In 1982, she was promoted to Senior Director of Environmental Control. 10 years later, she was appointed to the newly created position of Vice President of Environmental and Safety Policy. Committed to ensuring our company was a leader in protecting the environment, Dorothy spearheaded numerous processes for reducing the company\u2019s emissions and chemical releases, making MSD a model for the industry as one of the first companies to publicly commit to pollution reductions.<\/p>\n\n\n\n

By 1999, after 25 years with the company, Dorothy had helped elevate environment protection to be among our highest business priorities before her retirement.<\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

06.<\/p><\/div>

<\/div><\/div>
\n
\n
\n

Christine Stubbs,<\/h3>\n\n\n\n

the first woman to earn a chemical engineering degree from Howard University.<\/h4>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

Christine “Chris” Stubbs began working at MSD in 1983 as the first woman to earn an engineering degree from Howard University.<\/p>\n\n\n\n

From then, she was one of the company\u2019s most active employees in promoting equal opportunity. After 10 years with MSD, Chris managed materials logistics at the Flint River manufacturing facility in Albany, Georgia, where she supervised 31 employees. This alone was impressive, but it was her additional work promoting diversity that earned her recognition as one of the 1993 Black Engineers of the Year from US Black Engineer magazine.<\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

07.<\/p><\/div>

<\/div><\/div>
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Dr. Johnnetta B. Cole,<\/h3>\n\n\n\n

the first african-american female board member at MSD.<\/h4>\n\n\n\n

Dr. Cole joined the MSD Board of Directors in 1994 and retained the seat until 2009. <\/p>\n<\/div>\n<\/div>\n\n\n\n

She was also the first African-American president of the prestigious Spelman College for African-American Women and also the first African-American woman on the Board of Directors at the Coca-Cola Company.<\/p>\n\n\n\n

As early as 1997, Dr. Cole asserted that diversity was a smart investment for businesses, most notably stating, \u201cLet\u2019s address the question as to whether diversity in the American workforce is the right thing to do or the smart thing to do. The answer is: it is both.\u201d <\/p>\n<\/div><\/div>\n\n\n\n

<\/div>

08.<\/p><\/div>

<\/div><\/div>
\n
\n
\n

Deborah Dagit,<\/h3>\n\n\n\n

MSD\u2019s first Chief Diversity Officer.<\/h4>\n\n\n\n

Deborah Dagit worked as MSD’s first Diversity Officer for 12 years. <\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n

Deb, who had been instrumental in getting the 1990 Americans with Disabilities Act passed by Congress, helped our company tie diversity and inclusion initiatives directly to the company\u2019s business practices and results. In 2010, she established MSD\u2019s employee business resource groups (EBRGs)<\/a> that are still active today. Deb retired from our company in December 2012.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n

We promote innovation through diversity and inclusion<\/h2>\n\n\n\n

Worldwide, MSD promotes a working environment with the aim of making people feel comfortable regardless of culture, age, sexual orientation or gender. Diversity and inclusion<\/a> have been an integral part of the corporate culture for many years. This is also reflected in the numbers e.g., around 50% of those who fill management positions in Switzerland and worldwide are women.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

MSD Women’s Network<\/h2>\n\n\n\n

In 1995, a group of female MSD employees in the USA got together to found the MSD Women’s Network. The network is committed to gender equity. It now has 57 chapters worldwide and over 9,000 members, both women and men. <\/p>\n\n\n\n

In Switzerland, around 400 employees are involved with the MSD Women’s Network.<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

MSD as an employer<\/h2>\n\n\n\n

Would you like to work with us to further develop our medicines and healthcare solutions, to continuously improve medical care and to bring inspiration to new generations? Become part of our team!<\/p>\n\n\n\n

To the MSD job portal<\/a><\/strong><\/p>\n\n\n\n

<\/div>\n\n\n\n

CH-NON-02261, 05\/2025<\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"

We introduce eight remarkable women who have paved the way for future generations. We promote innovation through diversity and inclusion Worldwide, MSD promotes a working environment with the aim of making people feel comfortable regardless of culture, age, sexual orientation or gender. Diversity and inclusion have been an integral part of the corporate culture for […]<\/p>\n","protected":false},"featured_media":7757,"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"footnotes":""},"tags":[47],"content_topic":[52],"admin_field":[],"class_list":["post-7811","story","type-story","status-publish","has-post-thumbnail","hentry","tag-company","content_topic-diversity-and-inclusion"],"yoast_head":"\nWomen at MSD - MSD Switzerland I msd.ch<\/title>\n<meta name=\"description\" content=\"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Women at MSD - MSD Switzerland I msd.ch\" \/>\n<meta property=\"og:description\" content=\"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/\" \/>\n<meta property=\"og:site_name\" content=\"msd.ch\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-04T16:47:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2023\/06\/Frauen-bei-MSD1.png?w=2160\" \/>\n\t<meta property=\"og:image:width\" content=\"2160\" \/>\n\t<meta property=\"og:image:height\" content=\"2160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/\",\"url\":\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/\",\"name\":\"Women at MSD - MSD Switzerland I msd.ch\",\"isPartOf\":{\"@id\":\"https:\/\/www.msd.ch\/en\/#website\"},\"datePublished\":\"2025-05-02T11:45:00+00:00\",\"dateModified\":\"2025-05-04T16:47:36+00:00\",\"description\":\"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Stories\",\"item\":\"https:\/\/www.msd.ch\/en\/stories-archive\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Women at MSD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.msd.ch\/en\/#website\",\"url\":\"https:\/\/www.msd.ch\/en\/\",\"name\":\"msd.ch\",\"description\":\"MSD researches and develops medicines and vaccines to save lives and improve patients' health. In Switzerland, 1000 employees in Lucerne and Zurich are dedicated to this.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.msd.ch\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Women at MSD - MSD Switzerland I msd.ch","description":"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/","og_locale":"en_US","og_type":"article","og_title":"Women at MSD - MSD Switzerland I msd.ch","og_description":"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.","og_url":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/","og_site_name":"msd.ch","article_modified_time":"2025-05-04T16:47:36+00:00","og_image":[{"url":"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2023\/06\/Frauen-bei-MSD1.png?w=2160","width":2160,"height":2160,"type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/","url":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/","name":"Women at MSD - MSD Switzerland I msd.ch","isPartOf":{"@id":"https:\/\/www.msd.ch\/en\/#website"},"datePublished":"2025-05-02T11:45:00+00:00","dateModified":"2025-05-04T16:47:36+00:00","description":"In the company\u2019s more than 130-year history, many women have helped shape MSD. We are going to introduce eight of them.","breadcrumb":{"@id":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.msd.ch\/en\/stories\/women-at-msd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Stories","item":"https:\/\/www.msd.ch\/en\/stories-archive\/"},{"@type":"ListItem","position":2,"name":"Women at MSD"}]},{"@type":"WebSite","@id":"https:\/\/www.msd.ch\/en\/#website","url":"https:\/\/www.msd.ch\/en\/","name":"msd.ch","description":"MSD researches and develops medicines and vaccines to save lives and improve patients' health. In Switzerland, 1000 employees in Lucerne and Zurich are dedicated to this.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.msd.ch\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"extended_data":{"featured_image":"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2023\/06\/Frauen-bei-MSD1.png?w=1024","acf_fields":{"mco_page_tracking_data":"","page_text_direction_selection":"ltr","show_section":true,"related_content_section_heading":"Learn more about us","story_one_selection":"select","related_content_item_one":{"ID":3540,"post_author":"974","post_date":"2025-06-18 08:00:00","post_date_gmt":"2025-06-18 06:00:00","post_content":"<!-- wp:acf\/article-hero-block {\"name\":\"acf\/article-hero-block\",\"data\":{\"date_text\":\"\",\"_date_text\":\"mco_f1_date_text\",\"share_text\":\"\",\"_share_text\":\"mco_f1_share_text\"},\"mode\":\"edit\"} \/-->\n\n<!-- wp:spacer {\"height\":\"60px\"} -->\n<div style=\"height:60px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">What does the Swiss LGBTI-Label mean?<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>The Swiss LGBTI-Label is a seal of quality for organizations based in Switzerland, or Swiss organizations that work for the internal equality of LGBTI persons.<br><br>LGBTI means persons who differ from the majority of the population in their sexual orientation or gender identity.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"20px\"} -->\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">Diversity as a lived reality<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>At MSD Switzerland, diversity is not a short-term goal, but a central part of our corporate culture. We firmly believe that only a work environment in which all employees\u2014regardless of gender identity, sexual orientation, or physical characteristics\u2014feel safe and respected can foster innovation and sustainable business success.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"20px\"} -->\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">Swiss LGBTI Label \u2013 a sign of equality in practice<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>The Swiss LGBTI Label was developed by the networks <strong>Network (Gay Leadership)<\/strong> and <strong>Wybernet (Gay Professional Women)<\/strong>, in close collaboration with <strong>Transgender Network Switzerland, Pink Cross, LOS<\/strong> <strong>\u2013 Lesbenorganisation Schweiz<\/strong> and <strong>Rainbow Families<\/strong>.<br><br>The label is awarded based on a structured assessment process that takes into account factors such as organizational culture, leadership principles, HR processes, and internal communication.<br><br>Recertification takes place at regular intervals and confirms the company's ongoing commitment.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:spacer {\"height\":\"20px\"} -->\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:columns {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-columns are-vertically-aligned-center\"><!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:image {\"id\":9242,\"sizeSlug\":\"full\",\"linkDestination\":\"none\",\"align\":\"center\"} -->\n<figure class=\"wp-block-image aligncenter size-full\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2025\/07\/2025-LGBTI-Certificate.jpg\" alt=\"Swiss LGBTI-Label Awardees\" class=\"wp-image-9242\" \/><\/figure>\n<!-- \/wp:image --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:image {\"id\":7828,\"width\":\"256px\",\"height\":\"132px\",\"sizeSlug\":\"large\",\"linkDestination\":\"none\",\"align\":\"center\"} -->\n<figure class=\"wp-block-image aligncenter size-large is-resized\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2021\/06\/logo1.png?w=1024\" alt=\"Swiss LGBTI-Label Logo\" class=\"wp-image-7828\" style=\"width:256px;height:132px\" \/><\/figure>\n<!-- \/wp:image --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column {\"verticalAlignment\":\"center\"} -->\n<div class=\"wp-block-column is-vertically-aligned-center\"><!-- wp:image {\"id\":9243,\"sizeSlug\":\"full\",\"linkDestination\":\"none\",\"align\":\"center\"} -->\n<figure class=\"wp-block-image aligncenter size-full\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2025\/07\/2025-LGBTI-Certificate_2.jpg\" alt=\"Swiss LGBTI-Label Awards\" class=\"wp-image-9243\" \/><\/figure>\n<!-- \/wp:image --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:spacer {\"height\":\"20px\"} -->\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<!-- \/wp:spacer -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">Together for greater visibility<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>At MSD Switzerland, we are proud to once again hold the Swiss LGBTI-Label \u2013 as an expression of our belief that an inclusive workplace benefits everyone: our employees, our company, and society as a whole.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><br><sup>CH-NON-01248, 07\/2025<\/sup><\/p>\n<!-- \/wp:paragraph -->","post_title":"MSD Switzerland once again awarded with the Swiss LGBTI-Label","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"msd-switzerland-awarded-with-the-swiss-lgbti-label","to_ping":"","pinged":"","post_modified":"2025-07-09 13:17:19","post_modified_gmt":"2025-07-09 11:17:19","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.msd.ch\/en\/?post_type=story&p=3540","menu_order":0,"post_type":"story","post_mime_type":"","comment_count":"0","filter":"raw"},"story_two_selection":"select","related_content_item_two":{"ID":1853,"post_author":"282","post_date":"2025-02-11 08:00:00","post_date_gmt":"2025-02-11 07:00:00","post_content":"<!-- wp:acf\/article-hero-block {\"id\":\"block_608975efdf550\",\"name\":\"acf\/article-hero-block\",\"data\":{\"date_text\":\"\",\"_date_text\":\"mco_f1_date_text\",\"share_text\":\"\",\"_share_text\":\"mco_f1_share_text\"},\"align\":\"\",\"mode\":\"preview\"} \/-->\n\n<!-- wp:paragraph -->\n<p>HIV (human immunodeficiency virus) continues to be a major public health threat. The virus can lead to AIDS.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Since 1985, our company has been engaged in research and development (R&D) efforts in the prevention and treatment of HIV. Over the years, our scientists have made significant discoveries that changed the way HIV is treated.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Here are some historical moments highlighting this effort:<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:acf\/mco-article-slideshow {\"id\":\"block_60923db8205e4\",\"name\":\"acf\/mco-article-slideshow\",\"data\":{\"mco_article_slideshow_0_mco_article_slideshow_image\":1968,\"_mco_article_slideshow_0_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_0_mco_article_slideshow_caption\":\"In 1982, the U.S. Centers for Disease Control and Prevention first used the term \u201cAIDS,\u201d or acquired immune deficiency syndrome, to describe the clinical syndrome caused by the human immunodeficiency virus (HIV). Julie Gerberding, chief patient officer, recalls: \u201cI started my training at the University of California at San Francisco at the very beginning of the AIDS epidemic and took care of the earliest patients there who, in retrospect, we recognize had AIDS. It was a truly frightening disease. There were so many unknowns, including how it was transmitted.\u201d\",\"_mco_article_slideshow_0_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_0_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_0_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_1_mco_article_slideshow_image\":3819,\"_mco_article_slideshow_1_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_1_mco_article_slideshow_caption\":\"In the mid-1980s, MSD launched its HIV research program in response to what it perceived as a potential epidemic. Our scientists were among the first to discover and develop medicines for the treatment of HIV.\",\"_mco_article_slideshow_1_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_1_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_1_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_2_mco_article_slideshow_image\":1989,\"_mco_article_slideshow_2_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_2_mco_article_slideshow_caption\":\"We were the first to publish the crystal structure of HIV protease, which is an enzyme which is essential for virus infectivity.\",\"_mco_article_slideshow_2_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_2_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_2_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_3_mco_article_slideshow_image\":1990,\"_mco_article_slideshow_3_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_3_mco_article_slideshow_caption\":\"In 1992, MSD joined other pharmaceutical companies to create the Inter-Company Collaboration for AIDS Drug Development to research HIV treatments. By 1993, we were undertaking the biggest research program in our history, deploying more scientists to investigate AIDS than any other disease and testing tens of thousands of compounds.\",\"_mco_article_slideshow_3_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_3_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_3_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_4_mco_article_slideshow_image\":1991,\"_mco_article_slideshow_4_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_4_mco_article_slideshow_caption\":\"The HIV\/AIDS community continued to speak out for action. In 1995, Linda Distlerath, former executive director, Public Policy and MSD Research Laboratories Public Affairs, spent time reading letters sent from thousands of AIDS patients and activists urging MSD to produce a treatment for the disease quickly.\",\"_mco_article_slideshow_4_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_4_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_4_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_5_mco_article_slideshow_image\":1992,\"_mco_article_slideshow_5_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_5_mco_article_slideshow_caption\":\"After years of study and development, MSD developed one of the first protease inhibitors. In 1995, prior to FDA approval, in conjunction with the U.S. Food and Drug Administration, patients and HIV advocacy groups, MSD offered a program that made its new HIV treatment available at no cost to selective patients before it was commercially available.\",\"_mco_article_slideshow_5_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_5_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_5_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_6_mco_article_slideshow_image\":1993,\"_mco_article_slideshow_6_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_6_mco_article_slideshow_caption\":\"In 1996, the HIV treatment received FDA approval in a record-setting 42 days. It was an important early achievement in making HIV a survivable infection.\",\"_mco_article_slideshow_6_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_6_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_6_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_7_mco_article_slideshow_image\":1994,\"_mco_article_slideshow_7_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_7_mco_article_slideshow_caption\":\"In 2012, The NAMES Project Foundation \u2013 with support from MSD \u2013 launched Call My Name national tour to bring attention to the distressing trajectory of the HIV epidemic in the Black communities in the U.S. The tour included creating new panels for the AIDS memorial quilt and educational workshops in 10 high-prevalence cities.\",\"_mco_article_slideshow_7_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_7_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_7_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_8_mco_article_slideshow_image\":1995,\"_mco_article_slideshow_8_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_8_mco_article_slideshow_caption\":\"Daria Hazuda, VP, infectious disease discovery and chief scientific officer, MSD Exploratory Science Center has led the team working to identify new ways to attack and treat HIV.\",\"_mco_article_slideshow_8_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_8_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_8_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow_9_mco_article_slideshow_image\":1996,\"_mco_article_slideshow_9_mco_article_slideshow_image\":\"mco_article_slideshow_image_f9q8hyhfliu\",\"mco_article_slideshow_9_mco_article_slideshow_caption\":\"In 2021, we entered into an agreement with Gilead to work together in the global HIV community in the fight against HIV.\",\"_mco_article_slideshow_9_mco_article_slideshow_caption\":\"mco_article_slideshow_caption_f9q8hyhfliu\",\"mco_article_slideshow_9_mco_article_slideshow_credit\":\"\",\"_mco_article_slideshow_9_mco_article_slideshow_credit\":\"mco_article_slideshow_credit_f9q8hyhfliu\",\"mco_article_slideshow\":10,\"_mco_article_slideshow\":\"mco_article_slideshow_f9q8hyhfliu\"},\"align\":\"\",\"mode\":\"auto\",\"className\":\"mt-2 mb-2\"} \/-->\n\n<!-- wp:paragraph -->\n<p><sup>CH-NON-01219, 02\/2025<\/sup><\/p>\n<!-- \/wp:paragraph -->","post_title":"Our commitment to HIV treatments and prevention through the years","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"hiv","to_ping":"","pinged":"","post_modified":"2025-04-11 10:42:21","post_modified_gmt":"2025-04-11 08:42:21","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.msd.ch\/en\/?post_type=story&p=1853","menu_order":0,"post_type":"story","post_mime_type":"","comment_count":"0","filter":"raw"},"story_three_selection":"select","related_content_item_three":{"ID":1922,"post_author":"282","post_date":"2023-05-18 07:44:00","post_date_gmt":"2023-05-18 05:44:00","post_content":"<!-- wp:acf\/article-hero-block {\"id\":\"block_608a6f4d2a5c6\",\"name\":\"acf\/article-hero-block\",\"data\":{\"date_text\":\"\",\"_date_text\":\"mco_f1_date_text\",\"share_text\":\"\",\"_share_text\":\"mco_f1_share_text\"},\"align\":\"\",\"mode\":\"edit\"} \/-->\n\n<!-- wp:paragraph -->\n<p>There\u2019s no single or simple solution to the complex problem of AMR, but we\u2019re committed to investing our expertise and resources alongside our partners to get much-needed antibiotics to those who need them most. Lives are at risk, and the time to act is now.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>True to our company\u2019s longstanding tradition of preventing and treating infectious diseases, we\u2019re proud to commit to invest $100 million over 10 years in the new AMR Action Fund. Through this groundbreaking partnership of leading pharmaceutical companies, philanthropies, development banks and multilateral organizations, we aim to bridge the gap between the innovative early antibiotic pipeline and patients. New antibiotics are urgently needed. With this new fund for antibiotic research and development, our collective aim is to bring two to four new antibiotics to patients and physicians by the end of the decade.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3,\"className\":\"mb-2\"} -->\n<h3 class=\"mb-2\">Here are five key reasons to build on these collaborative efforts to address AMR:<\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:mccberg\/f7-listicle {\"className\":\"mt-2\"} -->\n<div class=\"wp-block-mccberg-f7-listicle mco-f7-block wrapper-story-narrower mt-2\"><!-- wp:mccberg\/f7-listicle-item {\"className\":\"mt-2\"} -->\n<div class=\"wp-block-mccberg-f7-listicle-item f7-listicle-item mt-2\"><div class=\"f7-listicle-header\"><div><\/div><div><p>01.<\/p><\/div><div><\/div><\/div><div class=\"f7-listicle-content\"><!-- wp:heading {\"level\":4} -->\n<h4>New antibiotics are urgently needed; however, there are relatively few in development.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>AMR is a naturally occurring phenomenon through which bacteria build up defenses against antibiotics. The nature of resistance means that there is a continual need to develop new antibiotics so we can stay a step ahead of resistant pathogens.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>MSD has remained committed to antibiotic R&D for over 80 years and brought forward new treatments each decade. However, major scientific, regulatory and economic challenges discourage innovation in antibiotics, resulting in a significant decline in the number of companies conducting antibiotic and antifungal R&D over the last two decades. Recognizing there is unlikely to be a one-size-fits-all solution to the problem, MSD and others have suggested a series of policy reforms across several regions of the world. However, time is running out. We need collaboration from policymakers across the globe to help antibiotic innovation flourish for decades to come.<\/p>\n<!-- \/wp:paragraph --><\/div><\/div>\n<!-- \/wp:mccberg\/f7-listicle-item -->\n\n<!-- wp:mccberg\/f7-listicle-item {\"headingText\":\"02.\"} -->\n<div class=\"wp-block-mccberg-f7-listicle-item f7-listicle-item\"><div class=\"f7-listicle-header\"><div><\/div><div><p>02.<\/p><\/div><div><\/div><\/div><div class=\"f7-listicle-content\"><!-- wp:heading {\"level\":4} -->\n<h4>Once new antibiotics are approved, they need to be used appropriately.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>While developing new antimicrobials is important, slowing resistance to current medicines is equally crucial. Appropriate antibiotic therapy can play an important role in treating patients with resistant infections and preserving the effectiveness of antibiotics.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>We must work together to implement evidence-based policies and programs that support the appropriate prescribing and use of antimicrobials. At MSD, we are making significant investments to support antimicrobial stewardship (AMS), helping hospitals around the world to develop and implement patient-centered AMS programs that are customized at the local level based on factors like epidemiology, clinical setting and resource availability. We also provide significant grant funding to support a wide range of AMS initiatives and collaborations.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":4} -->\n<h4>Some of our global contributions to AMS:<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":2020,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2021\/04\/Awards-icon.png?w=60\" alt=\"\" class=\"wp-image-2020\"\/><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Supported the development of several AMS Centers of Excellence throughout the world<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":2021,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2021\/04\/Hospital-icon.png?w=60\" alt=\"\" class=\"wp-image-2021\"\/><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Helped public health leaders effectively monitor and address emerging AMR infections, promote AMS and customize accepted AMS strategies to meet local needs<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns -->\n\n<!-- wp:columns -->\n<div class=\"wp-block-columns\"><!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":2023,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2021\/04\/Public-health-Leaders-icon.png?w=60\" alt=\"\" class=\"wp-image-2023\"\/><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Contributed toward meaningful standardized patient safety outcome measures for US hospital AMS programs<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column -->\n\n<!-- wp:column -->\n<div class=\"wp-block-column\"><!-- wp:image {\"id\":2022,\"width\":45,\"height\":62,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large is-resized\"><img src=\"https:\/\/www.msd.ch\/en\/wp-content\/uploads\/sites\/42\/2021\/04\/Microscope-icon.png?w=60\" alt=\"\" class=\"wp-image-2022\" width=\"45\" height=\"62\"\/><\/figure>\n<!-- \/wp:image -->\n\n<!-- wp:paragraph -->\n<p>Funded a round of Discovery Awards (small seed grants to help diagnostic innovators get their ideas off the ground and improve their chances of winning the UK-based Longitude Prize)<\/p>\n<!-- \/wp:paragraph --><\/div>\n<!-- \/wp:column --><\/div>\n<!-- \/wp:columns --><\/div><\/div>\n<!-- \/wp:mccberg\/f7-listicle-item -->\n\n<!-- wp:mccberg\/f7-listicle-item {\"headingText\":\"03.\"} -->\n<div class=\"wp-block-mccberg-f7-listicle-item f7-listicle-item\"><div class=\"f7-listicle-header\"><div><\/div><div><p>03.<\/p><\/div><div><\/div><\/div><div class=\"f7-listicle-content\"><!-- wp:heading {\"level\":4} -->\n<h4>We must track resistance trends and use the data to inform on prescribing.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>To ensure that antibiotics are being prescribed appropriately, clinical treatment guidelines must remain up-to-date and based on resistance trends. Surveillance studies can assist in identifying these trends in pathogen incidence and AMR, and can also identify emergent resistant strains.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>At MSD, we work with public health bodies, health care professionals and diagnostics companies to inform appropriate antibiotic use by sharing surveillance data. One of the largest AMR surveillance programs, our Study for Monitoring Antimicrobial Resistance Trends (SMART) program has collected approximately 500,000 bacterial isolates from 217 sites in 63 countries since 2002. This data can help to curb the development of AMR by informing adequate treatment plans and prescribing guidelines that ensure antibiotics are used appropriately.<\/p>\n<!-- \/wp:paragraph --><\/div><\/div>\n<!-- \/wp:mccberg\/f7-listicle-item -->\n\n<!-- wp:mccberg\/f7-listicle-item {\"headingText\":\"04.\"} -->\n<div class=\"wp-block-mccberg-f7-listicle-item f7-listicle-item\"><div class=\"f7-listicle-header\"><div><\/div><div><p>04.<\/p><\/div><div><\/div><\/div><div class=\"f7-listicle-content\"><!-- wp:heading {\"level\":4} -->\n<h4>We need to think beyond human health.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>The challenge of AMR is multifaceted, and we believe a One Health approach to creating policies is critical to attain optimal health for people, animals and our environment.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>When it comes to animal health, vaccines should be considered a first line of defense against bacterial and viral diseases. By preventing diseases, vaccines can help minimize the need for antibiotics. MSD Animal Health is one of the largest manufacturers of animal health vaccines, supplying over 100B doses each year. We are also engaged in collaborative efforts to ensure new and existing antibiotics are effective now and in the future for all species.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Protecting the environment through responsible manufacturing is another key component of the One Health approach. To combat rising levels of antibiotics in the environment, we have committed over $100 million to ensure factory discharges do not present a risk to human health or the environment. We also worked with our partners in the AMR Industry Alliance to inform science\u2010based manufacturing targets to help ensure robust scrutiny of industry manufacturing supply chains.<\/p>\n<!-- \/wp:paragraph --><\/div><\/div>\n<!-- \/wp:mccberg\/f7-listicle-item -->\n\n<!-- wp:mccberg\/f7-listicle-item {\"headingText\":\"05.\"} -->\n<div class=\"wp-block-mccberg-f7-listicle-item f7-listicle-item\"><div class=\"f7-listicle-header\"><div><\/div><div><p>05.<\/p><\/div><div><\/div><\/div><div class=\"f7-listicle-content\"><!-- wp:heading {\"level\":4} -->\n<h4>The time to act against AMR is now.<\/h4>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p>We have received ample warning signs of the dangers of AMR. With collaboration across the scientific community and policymakers, it is preventable.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>We all have a role to play as we look ahead to prepare for the next health crisis. We know that without action, AMR will have significant global consequences. We must act now to put measures in place to ensure we have the antibiotics we need for our generation and those to come.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><sup>CH-NON-01235, 05\/2023<\/sup><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><\/p>\n<!-- \/wp:paragraph --><\/div><\/div>\n<!-- \/wp:mccberg\/f7-listicle-item --><\/div>\n<!-- \/wp:mccberg\/f7-listicle -->","post_title":"Addressing antibiotic resistance is more critical than ever. Here\u2019s why.","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"antibiotic-resistance","to_ping":"","pinged":"","post_modified":"2023-05-18 08:34:31","post_modified_gmt":"2023-05-18 06:34:31","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.msd.ch\/en\/?post_type=story&p=1922","menu_order":0,"post_type":"story","post_mime_type":"","comment_count":"0","filter":"raw"},"scroll-to-top":false,"subheader_title":"In the company\u2019s more than 130-year history, many women have helped shape MSD. ","secondary_image":false,"video_hosting_selection":"youtube","youtube_url":"","primary_cta":"Read more","secondary_cta":"","heading_level":"","video_accessible_name":"","primary_cta_aria_label":"","secondary_cta_aria_label":""}},"_links":{"self":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/story\/7811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/story"}],"about":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/types\/story"}],"version-history":[{"count":21,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/story\/7811\/revisions"}],"predecessor-version":[{"id":9189,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/story\/7811\/revisions\/9189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/media\/7757"}],"wp:attachment":[{"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/media?parent=7811"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/tags?post=7811"},{"taxonomy":"content_topic","embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/content_topic?post=7811"},{"taxonomy":"Admin Field","embeddable":true,"href":"https:\/\/www.msd.ch\/en\/wp-json\/wp\/v2\/admin_field?post=7811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}